Suppr超能文献

非典型趋化因子受体的生物化学和生物学。

The biochemistry and biology of the atypical chemokine receptors.

机构信息

Institute of Infection, Immunity and Inflammation, Glasgow Biomedical Research Centre, University of Glasgow, Glasgow G12 8TA, UK.

出版信息

Immunol Lett. 2012 Jul 30;145(1-2):30-8. doi: 10.1016/j.imlet.2012.04.004.

Abstract

A subset of chemokine receptors, initially called "silent" on the basis of their apparent failure to activate conventional signalling events, has recently attracted growing interest due to their ability to internalize, degrade, or transport ligands and thus modify gradients and create functional chemokine patterns in tissues. These receptors recognize distinct and complementary sets of ligands with high affinity, are strategically expressed in different cellular contexts, and lack structural determinants supporting Gα(i) activation, a key signalling event in cell migration. This is in keeping with the hypothesis that they have evolved to fulfil fundamentally different functions to the classical signalling chemokine receptors. Based on these considerations, these receptors (D6, Duffy antigen receptor for chemokines (DARC), CCX-CKR1 and CXCR7) are now collectively considered as an emerging class of 'atypical' chemokine receptors. In this article, we review the biochemistry and biology of this emerging chemokine receptor subfamily.

摘要

一组趋化因子受体,最初被称为“沉默”,因为它们似乎无法激活传统的信号事件,最近由于它们能够内化、降解或转运配体,从而改变组织中的梯度并产生功能性趋化因子模式,因此引起了越来越多的关注。这些受体以高亲和力识别独特且互补的配体,在不同的细胞环境中表达,并且缺乏支持 Gα(i)激活的结构决定因素,Gα(i)激活是细胞迁移中的关键信号事件。这与它们进化以履行与经典信号趋化因子受体根本不同的功能的假设是一致的。基于这些考虑,这些受体(D6、趋化因子受体(DARC)、CCX-CKR1 和 CXCR7)现在被集体视为一类新兴的“非典型”趋化因子受体。在本文中,我们回顾了这个新兴趋化因子受体亚家族的生物化学和生物学。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验